| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(02)00804-6 |
| P698 | PubMed publication ID | 12804866 |
| P50 | author | José R Castón | Q41628600 |
| Jorge Martínez-Torrecuadrada | Q55091020 | ||
| J. Ignacio Casal | Q57416939 | ||
| P2093 | author name string | Albert Pagès-Manté | |
| Enric Espuña | |||
| Narciís Saubi | |||
| P2860 | cites work | Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity | Q33785446 |
| The maturation process of pVP2 requires assembly of infectious bursal disease virus capsids | Q34331914 | ||
| Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic | Q37353496 | ||
| Acute infectious bursal disease in poultry: a review | Q37382392 | ||
| C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly | Q39604999 | ||
| Genomic structure of the large RNA segment of infectious bursal disease virus | Q40417232 | ||
| Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development | Q40811637 | ||
| Different architectures in the assembly of infectious bursal disease virus capsid proteins expressed in insect cells | Q40837341 | ||
| Expression of ORF A1 of infectious bursal disease virus results in the formation of virus-like particles | Q41039790 | ||
| Immunogenic properties of rabbit haemorrhagic disease virus structural protein VP60 expressed by a recombinant baculovirus: an efficient vaccine | Q41261628 | ||
| Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus | Q41706492 | ||
| An international collaborative study of an anti-infectious bursal disease virus reference serum. | Q41952783 | ||
| Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7. | Q42064254 | ||
| Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins | Q42068721 | ||
| A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region in VP2. | Q42631793 | ||
| Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens. | Q44172730 | ||
| Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States | Q44896267 | ||
| Transfer of antibodies elicited by baculovirus-derived VP2 of a very virulent bursal disease virus strain to progeny of commercial breeder chickens | Q45386977 | ||
| Protection from IBDV-induced bursal damage by a recombinant fowlpox vaccine, fpIBD1, is dependent on the titre of challenge virus and chicken genotype | Q45741833 | ||
| Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2. | Q45749425 | ||
| Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens | Q45775183 | ||
| Molecular basis of antigenic variation in infectious bursal disease virus | Q45778525 | ||
| Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. | Q45782124 | ||
| A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens | Q45845818 | ||
| A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus. | Q45861659 | ||
| Production of porcine parvovirus empty capsids with high immunogenic activity | Q52443304 | ||
| Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine | Q68061467 | ||
| DNA-mediated vaccination against infectious bursal disease in chickens | Q74841448 | ||
| Acute infectious bursal disease in poultry: Isolation and characterisation of a highly virulent strain | Q81742063 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Infectious bursal disease virus | Q707615 |
| P304 | page(s) | 3342-3350 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines | |
| P478 | volume | 21 |
| Q44400704 | A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure. |
| Q40409120 | Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines |
| Q39028830 | Advances in vaccine research against economically important viral diseases of food animals: Infectious bursal disease virus |
| Q40680455 | An optimized, highly efficient, self-assembled, subvirus-like particle of infectious bursal disease virus (IBDV). |
| Q38019442 | An overview of infectious bursal disease |
| Q44405819 | Chimeric calicivirus-like particles elicit specific immune responses in pigs. |
| Q38003693 | Current status of vaccines against infectious bursal disease |
| Q37840709 | Current strategies for subunit and genetic viral veterinary vaccine development. |
| Q35622386 | Efficacy of VP2 protein expressed in E. coli for protection against highly virulent infectious bursal disease virus |
| Q38824834 | Efficient self-assembly and protective efficacy of infectious bursal disease virus-like particles by a recombinant baculovirus co-expressing precursor polyprotein and VP4. |
| Q45567592 | Enhancement of the immunogenicity of DNA vaccine against infectious bursal disease virus by co-delivery with plasmid encoding chicken interleukin 2. |
| Q40745349 | High level soluble expression and one-step purification of IBDV VP2 protein in Escherichia coli |
| Q45359054 | Induction of protective immunity in chickens immunized with plant-made chimeric Bamboo mosaic virus particles expressing very virulent Infectious bursal disease virus antigen |
| Q93189780 | Infectious bursal disease virus in chickens: prevalence, impact, and management strategies |
| Q45403033 | Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens |
| Q42002192 | Overexpression of recombinant infectious bursal disease virus (IBDV) capsid protein VP2 in the middle silk gland of transgenic silkworm |
| Q35077976 | Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris |
| Q33812653 | Subviral particle as vaccine and vaccine platform |
| Q36601830 | Vaccines for viral and parasitic diseases produced with baculovirus vectors |
| Q62128249 | Virus-like particle-based vaccines for animal viral infections |
| Q38059059 | Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development |
| Q37666808 | Virus-like particles as a vaccine delivery system: myths and facts |
| Q38019283 | Virus-like particles: the new frontier of vaccines for animal viral infections. |
Search more.